GlyProVac ApS
CVR: 39724758
Growing 109% p.a.Micro companyEstablished (7 yrs)Loss-making
Active
Overview
- Company type
- APS
- Anpartsselskab
- Founded
- 3.7.2018
Details
- Employees
- 3 employees
- 1 FTE
- (2018)
- Capital
- 155.104 kr.
Purpose
Selskabets formål er udvikle, kommercialisere, fremstille og sælge bakterielle vacciner.
Location
Financials
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | -2.1 mio. | -5.2 mio. | 4.6 mio. | -832 t. | 6 | |
History
Ownership
Owners
Rossi Finans ApS
CVR: 36932295
10-14,99%
I/S Rødeledsvej
CVR: 38873520
5-9,99%
GlycoPharma Holding ApS
CVR: 39691558
33,33-49,99%
GlyProVac ApS
CVR: 39724758
Management
Directors
Anders Boysen(ADM. DIR.)
Ann Zahle Andersen(DIREKTØR)
Board
Tommi Petteri Kainu(FORMAND)
Allan Rosetzsky(BESTYRELSESMEDLEM)
Ann Zahle Andersen(BESTYRELSESMEDLEM)
Kirsten Winther(BESTYRELSESMEDLEM)
Willem Adriaan de Jongh(BESTYRELSESMEDLEM)
Founders
Production units (1)
GlyProVac ApS
P-no: 1023796054
Rørhatten 4, 5220, Odense SØ
Fremstilling af farmaceutiske præparater
3 employees
Similar companies
Companies in the same industry and area